Cargando…

Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?

OBJECTIVE: An analysis of the SARS-CoV-2 pandemic impact in the Spanish Gaucher Disease (GD) community is presented here. PATIENTS & METHODS: The Spanish GD foundation (FEETEF) surveyed 113 GD patients from March 30 to April 27; all patients provided a verbal consent. RESULTS: 110 surveys were a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrade-Campos, Marcio, Escuder-Azuara, Beatriz, de Frutos, Laura López, Serrano-Gonzalo, Irene, Giraldo, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358160/ https://www.ncbi.nlm.nih.gov/pubmed/32688219 http://dx.doi.org/10.1016/j.bcmd.2020.102478

Ejemplares similares

Social distancing, home-infusion and oral therapy: Evolving paradigms on Gaucher disease management in Spain during COVID-19 pandemic
por: Andrade-Campos, Marcio M., et al.
Publicado: (2021)

Recommendations on the follow‐up of patients with Gaucher disease in Spain: Results from a Delphi survey
por: Giraldo, Pilar, et al.
Publicado: (2022)

Identification of risk features for complication in Gaucher’s disease patients: a machine learning analysis of the Spanish registry of Gaucher disease
por: Andrade-Campos, Marcio M., et al.
Publicado: (2020)

Novel Management and Screening Approaches for Haematological Complications of Gaucher’s Disease
por: Giraldo, Pilar, et al.
Publicado: (2021)

Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher’s disease
por: Roca-Espiau, Mercedes, et al.
Publicado: (2019)

Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously
por: Noya, MSoledad, et al.
Publicado: (2018)

Advantages of digital technology in the assessment of bone marrow involvement in Gaucher's disease
por: Valero-Tena, Esther, et al.
Publicado: (2023)

P1540: STUDY OF MIRNA EXPRESSION PROFILES IN GAUCHER PATIENTS AND THEIR RELATIONSHIP WITH THE SEVERITY OF BONE INVOLVEMENT
por: Serrano-Gonzalo, I., et al.
Publicado: (2022)

Serum Phospholipid Profile Changes in Gaucher Disease and Parkinson’s Disease
por: López de Frutos, Laura, et al.
Publicado: (2022)

Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease
por: Andrade-Campos, Marcio, et al.
Publicado: (2017)

Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula
por: Giraldo, Pilar, et al.
Publicado: (2012)

Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)
por: Zimran, Ari, et al.
Publicado: (2017)

Reconsidering unconscious persistence: Suppressing unwanted memories reduces their indirect expression in later thoughts
por: Wang, Yingying, et al.
Publicado: (2019)

Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
por: Hughes, Derralynn A., et al.
Publicado: (2022)

Gaucher Disease and Gaucher Cells
por: Gözdaşoğlu, Sevgi
Publicado: (2015)

Management goals of type 1 Gaucher disease in South Africa: An expert Delphi consensus document on good clinical practice
por: Louw, Vernon Johan, et al.
Publicado: (2023)

The Influence of Genetic Variability and Proinflammatory Status on the Development of Bone Disease in Patients with Gaucher Disease
por: Gervas-Arruga, Javier, et al.
Publicado: (2015)

Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain
por: Purriños-Hermida, M. Jesus, et al.
Publicado: (2018)

The cognitive profile of type 1 Gaucher disease patients
por: Biegstraaten, Marieke, et al.
Publicado: (2012)

Gestalt Reconsidered
por: Wheeler, Gordon
Publicado: (2013)

Reconsidering syphilis
por: Cameron, A.
Publicado: (2020)

A prospective investigation of direct and indirect home care activities in three rural Norwegian municipalities
por: Helgheim, Berit Irene, et al.
Publicado: (2018)

Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability
por: Casado, Virginia, et al.
Publicado: (2006)

Gaucher Cells or Pseudo-Gaucher Cells: That’s the Question
por: Gören Şahin, Deniz, et al.
Publicado: (2014)

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism
por: Furderer, Makaila L., et al.
Publicado: (2022)

P1541: PRELIMINARY RESULTS OF TWO YEARS FOLLOW-UP OF TYPE 1 GAUCHER DISEASE PATIENTS TREATED WITH ELIGLUSTAT IN TRAZELGA PROJECT.
por: Serrano-Gonzalo, I., et al.
Publicado: (2022)

Gaucher's disease
por: Bohra, Vijay, et al.
Publicado: (2011)

Gaucher’s Disease
Publicado: (1916)

Language aptitude reconsidered /
Publicado: (1990)

Robert Boyle reconsidered
por: Brock, William H
Publicado: (1995)

Reconsidering “What Works”
por: Tanner, Kimberly D.
Publicado: (2011)

Reconsidering science learning
por: Scanlon, Eileen, et al.
Publicado: (2004)

Reconsidering conceptual change
por: Limón, Margarita, et al.
Publicado: (2002)

Reconsidering Visual Search
por: Kristjánsson, Árni
Publicado: (2015)

The Whiplash Disease Reconsidered
por: Astrup, Jens, et al.
Publicado: (2022)

Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on “Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158”
por: Hughes, Derralynn A., et al.
Publicado: (2023)

Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain
por: Darbà, Josep, et al.
Publicado: (2015)

Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry
por: Rosenbloom, Barry E., et al.
Publicado: (2022)

Assessment of Macrophage Inflammatory Biomarkers and Neutrophil Extracellular Traps Associated Proteins in COVID-19 Patients
por: Lopez de Frutos, Laura, et al.
Publicado: (2021)

Gestalt reconsidered : a new approach to contact and resistance /
por: Wheeler, Gordon, 1949-
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_tb7qrjnsgcdeggfcek1gs1vljb